"The National Cancer Centre Singapore (NCCS) is a leading national and regional tertiary cancer centre with specialists who are experts in treating cancer. NCCS attends to the majority of cancer cases in Singapore’s public healthcare sector. In addition to offering holistic and multidisciplinary oncology care, our clinicians and scientists collaborate with local and international partners to conduct robust, cutting-edge clinical and translational research. To achieve the vision of being a global leading cancer centre, NCCS offers world class care and shares its depth of experience and expertise by training local and overseas medical professionals."

During the past decade, National Cancer Centre; Medical Oncology conducted 19 clinical trials. In the 10-year time frame, 19 clinical trials started and 10 clinical trials were completed, i.e. on average, 52.6% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 5 clinical trials were completed. i.e. 62.5% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "National Cancer Centre; Medical Oncology" #1 collaborator was "Hoffmann-La Roche" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "National Cancer Centre; Medical Oncology" are "Breast Cancer" (4 trials), "Non-Small Cell Lung Cancer" (3 trials), "Carcinoma, Non-Small-Cell Lung" (2 trials), "Solid Tumors" (2 trials) and "Advanced or Metastatic Esophageal Squamous Cell Carcinoma" (1 trials). Many other conditions were trialed in "National Cancer Centre; Medical Oncology" in a lesser frequency.

Most popular intervention types in "National Cancer Centre; Medical Oncology" are "Drug" (25 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Atezolizumab" (8 trials), "Carboplatin" (5 trials), "Docetaxel" (4 trials) and "Gemcitabine" (4 trials). Other intervention names were less common.

The vast majority of trials in "National Cancer Centre; Medical Oncology" are 25 trials for "All" genders.

Currently, there are NaN active trials in "National Cancer Centre; Medical Oncology". undefined are not yet recruiting, 7 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in National Cancer Centre; Medical Oncology, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in National Cancer Centre; Medical Oncology, 1 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".